價(jià)格 | ¥13800 | ¥17500 | ¥10600 |
包裝 | 50mg | 100mg | 25mg |
最小起訂量 | 1mg |
發(fā)貨地 | 上海 |
更新日期 | 2024-12-12 |
中文名稱:化合物 NAB-14 | 英文名稱:NAB-14 |
CAS:1237541-73-9 | 品牌: TargetMol |
產(chǎn)地: 美國(guó) | 保存條件: Shipping with blue ice. |
產(chǎn)品類別: 抑制劑 | |
貨號(hào): T61227 |
名稱 | NAB-14 |
描述 | NAB-14 is a powerful and selective chemical compound that acts as a non-competitive antagonist for GluN2C and GluN2D receptors. With an IC50 value of 580 nM for GluN1/GluN2D, NAB-14 demonstrates high potency. This compound exhibits a remarkable selectivity of more than 800-fold towards recombinant GluN2C and GluN2D when compared to GluN2A and GluN2B. Furthermore, NAB-14 possesses the ability to penetrate the blood-brain-barrier effectively [1]. |
體外活性 | NAB-14 (compound 14) shows inhibition with IC 50 s of 15 μM and 5.1 μM for GluN1/2AC1/2CC2 and GluN1/2AC1/2CC2 receptors, respectively [1]. NAB-14 (20 μM; 24 h) inhibits native GluN2D-containing receptors in brain slices with no effect on native GluN2A- or GluN2B-containing NMDARs in cultures cortical neurons [1]. NAB-14 (10 μM) reduces the peak amplitude of evoked EPSCs to 55 ± 3.0%, and significantly reduced the τW of EPSC deactivation [1]. NAB-14 (10 μM) decreases the peak amplitude and charge transfer of interneuron EPSCs to 59 ± 9.9% and 63 ± 9.7%, respectively. And NAB-14 decreases τW for interneuron EPSCs from 150 ± 12 ms to 101 ± 14 ms [1]. |
體內(nèi)活性 | NAB-14 (20 mg/kg; p.o.) shows high systemic exposure with peak brain free of 3.2 and 3.8 nM for mouse and rat, respectively [1]. Animal Model: Mice and rats [1] Dosage: 20 mg/kg Administration: P.o. Result: Showed high systemic exposure with peak brain free of 3.2 and 3.8 nM for mouse and rat, respectively. |
存儲(chǔ)條件 | Shipping with blue ice. |
成立日期 | 2013-04-18 (12年) | 注冊(cè)資本 | 566.265100萬(wàn)人民幣 |
員工人數(shù) | 100-500人 | 年?duì)I業(yè)額 | ¥ 1億以上 |
主營(yíng)行業(yè) | 天然產(chǎn)物,生化試劑,分子生物學(xué),分子砌塊,生物技術(shù)服務(wù) | 經(jīng)營(yíng)模式 | 貿(mào)易,工廠,試劑,定制,服務(wù) |
產(chǎn)品名稱 | 價(jià)格 | 公司名稱 | 報(bào)價(jià)日期 | |
---|---|---|---|---|
詢價(jià) |
VIP2年
|
陜西締都新材料有限公司
|
2024-12-18 | |
詢價(jià) |
VIP1年
|
青島愷潤(rùn)生物醫(yī)藥科技有限公司
|
2025-01-19 | |
詢價(jià) |
VIP3年
|
陜西締都新材料有限公司
|
2024-12-18 |